These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29712879)

  • 1. Low Levels of Caveolin-1 Predict Symptomatic Bleeding After Thrombolytic Therapy in Patients With Acute Ischemic Stroke.
    Castellanos M; van Eendenburg C; Gubern C; Kádár E; Huguet G; Puig J; Sobrino T; Blasco G; Serena J; Sánchez JM
    Stroke; 2018 Jun; 49(6):1525-1527. PubMed ID: 29712879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group.
    Jaillard A; Cornu C; Durieux A; Moulin T; Boutitie F; Lees KR; Hommel M
    Stroke; 1999 Jul; 30(7):1326-32. PubMed ID: 10390303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
    Castellanos M; Leira R; Serena J; Blanco M; Pedraza S; Castillo J; Dávalos A
    Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed Tomography--Verified Leukoaraiosis Is a Risk Factor for Post-thrombolytic Hemorrhage.
    Willer L; Havsteen I; Ovesen C; Christensen AF; Christensen H
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1126-30. PubMed ID: 25920756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke.
    Choi KH; Park MS; Kim JT; Nam TS; Choi SM; Kim BC; Kim MK; Cho KH
    Eur J Neurol; 2012 Apr; 19(4):570-7. PubMed ID: 21999175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonographic evaluation of hemorrhagic transformation and arterial recanalization in acute hemispheric ischemic stroke.
    Seidel G; Cangür H; Albers T; Burgemeister A; Meyer-Wiethe K
    Stroke; 2009 Jan; 40(1):119-23. PubMed ID: 18988915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.
    Foerch C; Wunderlich MT; Dvorak F; Humpich M; Kahles T; Goertler M; Alvarez-Sabín J; Wallesch CW; Molina CA; Steinmetz H; Sitzer M; Montaner J
    Stroke; 2007 Sep; 38(9):2491-5. PubMed ID: 17673718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke.
    Vo KD; Santiago F; Lin W; Hsu CY; Lee Y; Lee JM
    AJNR Am J Neuroradiol; 2003 Apr; 24(4):674-9. PubMed ID: 12695202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
    Ribo M; Montaner J; Molina CA; Arenillas JF; Santamarina E; Quintana M; Alvarez-Sabín J
    Stroke; 2004 Sep; 35(9):2123-7. PubMed ID: 15243150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
    Castellanos M; Sobrino T; Millán M; García M; Arenillas J; Nombela F; Brea D; Perez de la Ossa N; Serena J; Vivancos J; Castillo J; Dávalos A
    Stroke; 2007 Jun; 38(6):1855-9. PubMed ID: 17478737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke.
    Jucevičiūtė N; Mikužis P; Balnytė R
    BMC Neurol; 2019 Jun; 19(1):127. PubMed ID: 31195995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.